'Hold accountable those opposed to global access to COVID-19 vaccines'
March 2, 2021 A patient getting a COVID-19 jab Drawing from the 2030 Agenda for Sustainable Development (AfSD) vision to ‘leave no one behind’, particularly low-income countries, a research report on COVID-19 vaccines and treatments, contends that more big pharmaceutical companies need to buy into the COVAX initiative. COVID-19 Vaccines Global Access, abbreviated as COVAX, is a global initiative aimed at equitable access to COVID-19 vaccines led by the Global Alliance for Vaccines and Immu...
Source: observer.ug